Hanna Cho Selected Research

5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)

1/2021	Association of Dipeptidyl Peptidase-4 Inhibitor Use and Amyloid Burden in Patients With Diabetes and AD-Related Cognitive Impairment.
1/2020	Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients.
1/2020	The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease.
10/2016	The Role of Cerebrovascular Disease in Amyloid Deposition.
11/2013	Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.
5/2013	Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hanna Cho Research Topics

Disease

28	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2013
26	Cognitive Dysfunction 01/2021 - 05/2013
16	Dementia (Dementias) 01/2022 - 01/2015
10	Neoplasms (Cancer) 01/2021 - 02/2008
9	Atrophy 01/2019 - 01/2012
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020 - 11/2013
4	Cerebral Cortical Thinning 01/2019 - 01/2012
4	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2018 - 01/2012
3	Ischemia 01/2018 - 04/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2018
2	Primary Progressive Aphasia 01/2021 - 01/2016
2	Prodromal Symptoms 01/2021 - 05/2014
2	Memory Disorders (Memory Loss) 11/2020 - 01/2018
2	Cerebral Small Vessel Diseases 01/2018 - 01/2016
2	Melanoma (Melanoma, Malignant) 09/2010 - 02/2008
1	Wounds and Injuries (Trauma) 09/2022
1	Bacterial Infections (Bacterial Infection) 09/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021
1	Body Weight Changes 01/2021
1	Amyloidosis 10/2020
1	Sarcoma (Soft Tissue Sarcoma) 07/2020
1	Prediabetic State (Prediabetes) 01/2020
1	Anosmia 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Gliosis 08/2019
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 08/2019
1	Acquired CJD 08/2019
1	Sporadic Creutzfeldt-Jakob Disease 08/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Carcinogenesis 01/2019
1	Stroke (Strokes) 06/2018
1	Infarction (Infarctions) 06/2018
1	Frontotemporal Dementia (Semantic Dementia) 01/2018
1	Lewy Body Disease (Lewy Body Dementia) 01/2018
1	Cerebral Hemorrhage 01/2017
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2017
1	Siderosis 01/2017
1	Thyroid Neoplasms (Thyroid Cancer) 01/2016
1	Disease Progression 01/2016
1	Spastic Paraparesis 01/2016
1	Aphasia (Dysphasia) 01/2016
1	Endometrial Neoplasms (Endometrial Cancer) 10/2015
1	Parkinson Disease (Parkinson's Disease) 01/2015
1	Amyloid angiopathy 05/2014
1	Lacunar Stroke 11/2013
1	Muscular Diseases (Myopathy) 10/2013
1	Distal Myopathies (Distal Muscular Dystrophy) 10/2013

Drug/Important Bio-Agent (IBA)

40	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2012
11	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2021 - 01/2018
8	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2016 - 01/2012
6	5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA 01/2021 - 05/2013
6	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 11/2020 - 01/2016
5	Apolipoproteins E (ApoE)IBA 01/2021 - 11/2013
5	Apolipoprotein E4IBA 01/2020 - 11/2013
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	ApolipoproteinsIBA 10/2020 - 11/2013
3	Amyloid beta-PeptidesIBA 01/2022 - 11/2013
3	Phosphotransferases (Kinase)IBA 01/2021 - 01/2016
2	AZD4547IBA 01/2021 - 10/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 10/2018
2	THK5351IBA 08/2019 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 09/2010 - 02/2008
1	Penicillins (Penicillin)FDA Link 09/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	tau Proteins (tau Protein)IBA 10/2021
1	PolymersIBA 10/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	FluorineIBA 01/2021
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 01/2021
1	TropomyosinIBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	PF-562271IBA 01/2021
1	DNA-Binding Proteins (DNA Binding Protein)IBA 07/2020
1	florbetapirIBA 01/2020
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	SAR131675IBA 10/2019
1	LigandsIBA 08/2019
1	Monoamine Oxidase (MAO)IBA 08/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Pyruvic Acid (Pyruvate)IBA 01/2019
1	satraplatin (JM 216)IBA 01/2019
1	CholesterolIBA 10/2018
1	N- (4- methyl- 3- (1- methyl- 7- (6- methylpyridin- 3- ylamino)- 2- oxo- 1,2- dihydropyrimido(4,5- d)pyrimidin- 3(4H)- yl)phenyl)- 3- (trifluoromethyl)benzamideIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 10/2015
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2015
1	Pemetrexed (MTA)FDA Link 04/2014
1	Uridine Diphosphate (UDP)IBA 10/2013
1	EnzymesIBA 10/2013
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2013

Therapy/Procedure

2	Oral Administration 01/2021 - 10/2015
1	Maggot Debridement Therapy 09/2022
1	Long-Term Care 01/2021
1	Cognitive Training 01/2015